Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | TP53 |
| Variant | R280K |
| Impact List | missense |
| Protein Effect | gain of function |
| Gene Variant Descriptions | TP53 R280K lies within the DNA-binding domain of the Tp53 protein (PMID: 22713868). R280K results in interaction with Tbk1 leading to decreased Tbk1 and Irf3 phosphorylation and loss of Irf3 activation in culture (PMID: 33545063), decreased activation and repression of wild-type Tp53 target genes (PMID: 17070499, PMID: 16322760, PMID: 18472962), as well as a gain of function in activation of novel targets, and leads to increased cell migration and invasion, and increased cell survival (PMID: 18472962, PMID: 24763051). |
| Associated Drug Resistance | |
| Category Variants Paths |
TP53 mutant TP53 act mut TP53 R280K TP53 mutant TP53 exon8 TP53 R280K |
| Transcript | NM_000546.6 |
| gDNA | chr17:g.7673781C>T |
| cDNA | c.839G>A |
| Protein | p.R280K |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_001407268.1 | chr17:g.7673781C>T | c.839G>A | p.R280K | RefSeq | GRCh38/hg38 |
| NM_001126112.3 | chr17:g.7673781C>T | c.839G>A | p.R280K | RefSeq | GRCh38/hg38 |
| NM_001126114 | chr17:g.7673781C>T | c.839G>A | p.R280K | RefSeq | GRCh38/hg38 |
| NM_000546.5 | chr17:g.7673781C>T | c.839G>A | p.R280K | RefSeq | GRCh38/hg38 |
| NM_001126113.2 | chr17:g.7673781C>T | c.839G>A | p.R280K | RefSeq | GRCh38/hg38 |
| NM_001407264.1 | chr17:g.7673781C>T | c.839G>A | p.R280K | RefSeq | GRCh38/hg38 |
| NM_001407270.1 | chr17:g.7673781C>T | c.839G>A | p.R280K | RefSeq | GRCh38/hg38 |
| NM_001407262.1 | chr17:g.7673781C>T | c.839G>A | p.R280K | RefSeq | GRCh38/hg38 |
| NM_000546 | chr17:g.7673781C>T | c.839G>A | p.R280K | RefSeq | GRCh38/hg38 |
| NM_001407266.1 | chr17:g.7673781C>T | c.839G>A | p.R280K | RefSeq | GRCh38/hg38 |
| NM_001126112 | chr17:g.7673781C>T | c.839G>A | p.R280K | RefSeq | GRCh38/hg38 |
| NM_000546.6 | chr17:g.7673781C>T | c.839G>A | p.R280K | RefSeq | GRCh38/hg38 |
| NM_001126112.2 | chr17:g.7673781C>T | c.839G>A | p.R280K | RefSeq | GRCh38/hg38 |
| NM_001126114.3 | chr17:g.7673781C>T | c.839G>A | p.R280K | RefSeq | GRCh38/hg38 |
| NM_001126113 | chr17:g.7673781C>T | c.839G>A | p.R280K | RefSeq | GRCh38/hg38 |
| NM_001126114.2 | chr17:g.7673781C>T | c.839G>A | p.R280K | RefSeq | GRCh38/hg38 |
| NM_001126113.3 | chr17:g.7673781C>T | c.839G>A | p.R280K | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|